Caplight Directory>Companies>Averywell-preview>Averywell


Averywell

Averywell

Private
ManchesterHealthcare & Life Scienceshttps://averywell.com/

Last Round

Pre Seed

Apr 27, 2024

Momentum Score

25 /100

Company Overview

Averywell is a med-tech company that develops a non-invasive, miRNA-based liquid biopsy technology for early lung cancer detection and management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

liquid biopsylung cancer screeninglung cancer blood testnon-invasive diagnosticsAI diagnosticsmicroRNA biomarkersearly cancer detectionprecision medicineMedTechlung nodule management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Averywell Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Averywell Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 27, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Cherry NY CHIA

Founder & CEO

Founding Team

Averywell Investors

Notable investors and investment history

InvestorRounds
Barclays Eagle LabsAccelerator
Genesis VenturesPre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2026

    Grew 150% QoQ, from 2 to 5 employees.

  • Jun 1, 2025

    Monthly visitors grew 159% MoM, reaching 2.3K.

View all signals

Averywell Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Averywell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Averywell's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester
Employee Range3
Year Founded2023
Last FundingApr 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.